Aprea TherapeuticsAPRE
13F holders, Q2 2024 (June 30)27holders +5
6new positions
2sold out
$4.07avg. 13F price*
At the end of Q2 2024, 27 institutions reported holding Aprea Therapeutics Inc. (APRE) in their 13F filings, up 5 from Q1 2024. 6 opened new positions and 2 sold out. The largest holders were AIGH Capital Management LLC ($2.2M), Sio Capital Management, LLC ($1.1M) and Sphera Funds Management LTD. ($1.1M).
- Company
- Aprea Therapeutics Inc.
- CUSIP
- 03836J201
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $1.8M |
| Exits | 2 | $1K |
All 13F filers, Q1 2024 → Q2 2024: 459,214 shares bought and 573 shares sold, net +458,641 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| AIGH Capital Management LLC | 1.07% | No change | 539,300 | $2.2M |
| Sio Capital Management, LLC | 0.42% | No change | 276,603 | $1.1M |
| Sphera Funds Management LTD. | 0.18% | No change | 270,000 | $1.1M |
| Nantahala Capital Management, LLC | 0.08% | No change | 205,760 | $837K |
| Altium Capital Management LLC | 0.23% | New | 137,197 | $558K |
| Stonepine Capital Management, LLC | 0.51% | New | 137,174 | $558K |
| Exome Asset Management LLC | 0.50% | New | 137,174 | $558K |
| DAFNA Capital Management LLC | 0.13% | No change | 137,174 | $558K |
| Vanguard Group Inc. | 0.00% | Reduce -0.1% | 115,838 | $471K |
| Geode Capital Management, LLC | 0.00% | Add +76.4% | 35,673 | $145K |
| Morgan Stanley | 0.00% | Add +11.2% | 29,818 | $121K |
| HighTower Advisors, LLC | 0.00% | No change | 13,864 | $56K |
| Dimensional Fund Advisors LP | 0.00% | New | 11,071 | $45K |
| Susquehanna International Group, LLP | 0.00% | New | 10,119 | $41K |
| BlackRock Inc. | 0.00% | No change | 8,504 | $35K |
| Royal Bank of Canada | 0.00% | Add +121.6% | 5,694 | $23K |
| Bank of America Corp. | 0.00% | Add +209.9% | 4,853 | $20K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +142.4% | 2,730 | $11K |
| Group One Trading LLC | 0.00% | No change | 2,160 | $9K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 1,000 | $4K |
| Mb, Levis & Associates, LLC | 0.00% | No change | 806 | $3K |
| Wells Fargo & Company | 0.00% | Reduce -8.1% | 250 | $1K |
| WealthCollab, LLC | 0.00% | No change | 158 | $644 |
| Osaic Holdings, Inc. | 0.00% | Reduce -66.7% | 100 | $407 |
| JPMorgan Chase & Co. | 0.00% | New | 12 | $49 |
| Aviso Financial Inc. | 0.00% | — | 10 | $41 |
| UBS Group AG | 0.00% | No change | 3 | $12 |
"% of holder's portfolio" is APRE's weight in each manager's 13F, not the share of Aprea Therapeutics Inc. the manager owns.